The majority of their inherited risk would be due to a discoverable BRCA1/2 mutation and the negative test will greatly reduce their risk of breast and ovarian cancer, due to the high sensitivity of current BRCA testing [18]. Here, BRCA1 is linked to ovarian cancer.